Hoplite Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Hoplite Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-274,731	Closed	-$56.7M	–	25
2018 Q1	$56.7M	Sell	274,731 -93,108	-25%	-$19.5M	4.06%	14
2017 Q4	$69.8M	Buy	367,839 +18,715	+5%	+$3.59M	4.86%	8
2017 Q3	$66.1M	Buy	+349,124	New	+$63.2M	4.2%	15
2014 Q4	–	Sell	-865,017	Closed	-$105M	–	38
2014 Q3	$105M	Buy	+865,017	New	+$105M	2.69%	19
2014 Q1	–	Sell	-952,437	Closed	-$106M	–	46
2013 Q4	$106M	Hold	952,437	–	–	2.98%	11
2013 Q3	$87.8M	Hold	952,437	–	–	3.12%	14
2013 Q2	$80.6M	Buy	+952,437	New	+$79.3M	2.81%	14

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hoplite Capital Management's TMO Position: Q2 2018 in Review

Hoplite Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2018, closing a stake of 274,731 shares — an estimated $56.7M sold.

Hoplite Capital Management first reported a position in TMO in Q2 2013 and held it in 7 quarters. The position peaked at $106M in Q4 2013. 1,322 funds tracked by Wall St. Rank hold TMO as of Q2 2018.

Hoplite Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2018 after selling out during the quarter.
Hoplite Capital Management sold 274,731 Thermo Fisher Scientific shares in Q2 2018, an estimated $56.7M.
Hoplite Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 7 quarters.
Hoplite Capital Management's Thermo Fisher Scientific position peaked at $106M in Q4 2013.
1,322 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2018.

Based on Hoplite Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.